Page last updated: 2024-10-20

pyridoxal phosphate and Primary Graft Dysfunction

pyridoxal phosphate has been researched along with Primary Graft Dysfunction in 1 studies

Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.

Primary Graft Dysfunction: A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben Mosbah, I1
Mouchel, Y1
Pajaud, J1
Ribault, C1
Lucas, C1
Laurent, A1
Boudjema, K1
Morel, F1
Corlu, A1
Compagnon, P1

Other Studies

1 other study available for pyridoxal phosphate and Primary Graft Dysfunction

ArticleYear
Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.
    PloS one, 2012, Volume: 7, Issue:11

    Topics: Adenosine Triphosphate; Animals; Antioxidants; Apoptosis; Catalase; Edetic Acid; Gene Expression; Gr

2012